Jack Antel is a clinical neurologist who coordinates the multiple sclerosis research and treatment program at the Montreal Neurological Institute.

He is a Professor at McGill University where he has served as Chairman of the Department of Neurology and Neurosurgery. He is President of ACTRIMS. He was the initial director of the Canadian Institute of Health Research supported training programme in neuro-inflammation. Dr. Antel served as Chairman of the Medical Advisory Board of the Multiple Sclerosis Society of Canada from January 2004 to 2007. From 2004 to 2006 he served as President of the International Society of Neuroimmunology. From 2007 to 2015 he was the National Scientific Director of the endMS Research and Training Network supported by the MS Society of Canada. Prior to his work at McGill University, Dr. Antel was Professor of Neurology at the University of Chicago. His research interests include understanding the mechanisms of tissue injury and repair that account for the characteristic disease course of multiple sclerosis and how these can be therapeutically targeted. Dr. Antel was the recipient of the 2005 Dystel Award from the National Multiple Sclerosis Society and the American Academy of Neurology. He currently is the Editor for the Americas of the Multiple Sclerosis Journal.